Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease. - Smeijer, J. David; Kohan, Donald E.; Rossing, Peter; Correa-Rotter, Ricardo; Liew, Adrian; Tang, Sydney C.W.; de Zeeuw, Dick; Gansevoort, Ron T.; Ju, Wenjun; Lambers Heerspink, Hiddo J. (Cardiovascular Diabetology, 2023)